Pfizer To Review TBWA-Held Brand

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Pfizer has placed Omnicom Group’s TBWA\Chiat\Day on 90-day notice for its Aricept brand, which the New York shop has handled since 1996, sources said. Billing on the account, which encompasses direct-to-consumer creative duties, is estimated at $20 million. Sources expect Pfizer to launch a review of the business.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in